_id
6919e8643c536f8df231824e
Ticker
GDR.LSE
Name
genedrive plc
Exchange
LSE
Address
The Incubator Building, Manchester, United Kingdom, M13 9XX
Country
UK
Sector
Healthcare
Industry
Diagnostics & Research
Currency
GBX
Website
https://www.genedriveplc.com
Description
genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides Genedrive system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a certified test for identification of individuals unlikely to respond to the commonly prescribed antiplatelet drug Clopidogrel. It also offers Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and tests for the detection of Antibiotic Induced Hearing Loss in neonates, confirmation of HCV infection prior to drug administration, pathogen detection of biological military threats and a point-of-care for COVID-19 detection system for use in areas, such as healthcare, workplace screening, travel requirements, and confirmation of antigen tests. It serves medical, biotechnology, and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. The company was founded in 2000 and is headquartered in Manchester, the United Kingdom.
Last Close
8250
Volume
2796792
Current Price
0.985
Change
-3.0303030303030196
Last Updated
2025-12-30T10:57:29.738Z
Image
https://logo.clearbit.com/www.genedriveplc.com
Ipo Date
-
Market Cap
8494232
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
604000
Cost Of Revenue
-
Gross Profit
457000
Operating Expenses
3267000
Operating Income
-2810000
Interest Expense
-
Pretax Income
-2897000
Net Income
-2902000
Eps
-0.004643977156574016
Dividends Per Share
-
Shares Outstanding
1029603992
Income Tax Expense
5000
EBITDA
-2873000
Operating Margin
-465.2317880794702
Total Other Income Expense Net
-87000
Cash
1182000
Short Term Investments
-
Receivables
1075000
Inventories
428000
Total Current Assets
2685000
Property Plant Equipment
130000
Total Assets
2815000
Payables
589000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1377000
Equity
1438000
Bs_currency_symbol
GBP
Depreciation
24000
Change In Working Capital
222000
Cash From Operations
-2044000
Capital Expenditures
9000
Cash From Investing
-9000
Cash From Financing
1137000
Net Change In Cash
-916000
Cf_currency_symbol
-
PE
-
PB
428.04031771905426
ROE
-201.80806675938805
ROA
-103.09058614564832
FCF
-2053000
Fcf Percent
-3.3990066225165565
Piotroski FScore
1
Health Score
23
Deep Value Investing Score
2.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
4
Growth Investing Score
3
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
4
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
604000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
457000
Quarters > 0 > income Statement > operating Expenses
3267000
Quarters > 0 > income Statement > operating Income
-2810000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-2897000
Quarters > 0 > income Statement > net Income
-2902000
Quarters > 0 > income Statement > eps
-0.004643977156574016
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
624895408
Quarters > 0 > income Statement > income Tax Expense
5000
Quarters > 0 > income Statement > EBITDA
-2873000
Quarters > 0 > income Statement > operating Margin
-465.2317880794702
Quarters > 0 > income Statement > total Other Income Expense Net
-87000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1182000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1075000
Quarters > 0 > balance Sheet > inventories
428000
Quarters > 0 > balance Sheet > total Current Assets
2685000
Quarters > 0 > balance Sheet > property Plant Equipment
130000
Quarters > 0 > balance Sheet > total Assets
2815000
Quarters > 0 > balance Sheet > payables
589000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1377000
Quarters > 0 > balance Sheet > equity
1438000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-2902000
Quarters > 0 > cash Flow > depreciation
24000
Quarters > 0 > cash Flow > change In Working Capital
222000
Quarters > 0 > cash Flow > cash From Operations
-2044000
Quarters > 0 > cash Flow > capital Expenditures
9000
Quarters > 0 > cash Flow > cash From Investing
-9000
Quarters > 0 > cash Flow > cash From Financing
1137000
Quarters > 0 > cash Flow > net Change In Cash
-916000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.004643977156574016
Quarters > 0 > ratios > PB
428.04031771905426
Quarters > 0 > ratios > ROE
-201.80806675938805
Quarters > 0 > ratios > ROA
-103.09058614564832
Quarters > 0 > ratios > FCF
-2053000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-3.3990066225165565
Quarters > 0 > health Score
23
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
350000
Quarters > 1 > income Statement > cost Of Revenue
43000
Quarters > 1 > income Statement > gross Profit
307000
Quarters > 1 > income Statement > operating Expenses
2877000
Quarters > 1 > income Statement > operating Income
-2570000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-2529000
Quarters > 1 > income Statement > net Income
-2329000
Quarters > 1 > income Statement > eps
-0.012303080584670703
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
189302182
Quarters > 1 > income Statement > income Tax Expense
-200000
Quarters > 1 > income Statement > EBITDA
-2486000
Quarters > 1 > income Statement > operating Margin
-734.2857142857142
Quarters > 1 > income Statement > total Other Income Expense Net
41000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
2098000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1397000
Quarters > 1 > balance Sheet > inventories
366000
Quarters > 1 > balance Sheet > total Current Assets
3861000
Quarters > 1 > balance Sheet > property Plant Equipment
145000
Quarters > 1 > balance Sheet > total Assets
4006000
Quarters > 1 > balance Sheet > payables
936000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
936000
Quarters > 1 > balance Sheet > equity
3070000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-2329000
Quarters > 1 > cash Flow > depreciation
43000
Quarters > 1 > cash Flow > change In Working Capital
-611000
Quarters > 1 > cash Flow > cash From Operations
-3057000
Quarters > 1 > cash Flow > capital Expenditures
14000
Quarters > 1 > cash Flow > cash From Investing
-14000
Quarters > 1 > cash Flow > cash From Financing
-19000
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.012303080584670703
Quarters > 1 > ratios > PB
60.73701930618892
Quarters > 1 > ratios > ROE
-75.86319218241042
Quarters > 1 > ratios > ROA
-58.137793310034944
Quarters > 1 > ratios > FCF
-3071000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-8.774285714285714
Quarters > 1 > health Score
26
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
263000
Quarters > 2 > income Statement > cost Of Revenue
129000
Quarters > 2 > income Statement > gross Profit
134000
Quarters > 2 > income Statement > operating Expenses
3087000
Quarters > 2 > income Statement > operating Income
-2953000
Quarters > 2 > income Statement > interest Expense
4000
Quarters > 2 > income Statement > pretax Income
-5361000
Quarters > 2 > income Statement > net Income
-5036000
Quarters > 2 > income Statement > eps
-0.02709308747471879
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
185877671
Quarters > 2 > income Statement > income Tax Expense
-325000
Quarters > 2 > income Statement > EBITDA
-5228000
Quarters > 2 > income Statement > operating Margin
-1122.8136882129277
Quarters > 2 > income Statement > total Other Income Expense Net
-2408000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
5188000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
125000
Quarters > 2 > balance Sheet > inventories
381000
Quarters > 2 > balance Sheet > total Current Assets
6626000
Quarters > 2 > balance Sheet > property Plant Equipment
174000
Quarters > 2 > balance Sheet > total Assets
6800000
Quarters > 2 > balance Sheet > payables
665000
Quarters > 2 > balance Sheet > short Term Debt
19000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1441000
Quarters > 2 > balance Sheet > equity
5359000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-5036000
Quarters > 2 > cash Flow > depreciation
129000
Quarters > 2 > cash Flow > change In Working Capital
624000
Quarters > 2 > cash Flow > cash From Operations
-1328000
Quarters > 2 > cash Flow > capital Expenditures
24000
Quarters > 2 > cash Flow > cash From Investing
-24000
Quarters > 2 > cash Flow > cash From Financing
5324000
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.02709308747471879
Quarters > 2 > ratios > PB
34.16486395502892
Quarters > 2 > ratios > ROE
-93.97275611121478
Quarters > 2 > ratios > ROA
-74.05882352941177
Quarters > 2 > ratios > FCF
-1352000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-5.140684410646388
Quarters > 2 > health Score
27
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
238000
Quarters > 3 > income Statement > cost Of Revenue
118000
Quarters > 3 > income Statement > gross Profit
120000
Quarters > 3 > income Statement > operating Expenses
2479000
Quarters > 3 > income Statement > operating Income
-2359000
Quarters > 3 > income Statement > interest Expense
8000
Quarters > 3 > income Statement > pretax Income
-2389000
Quarters > 3 > income Statement > net Income
-2039000
Quarters > 3 > income Statement > eps
-0.01569963691798495
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
129875615
Quarters > 3 > income Statement > income Tax Expense
-350000
Quarters > 3 > income Statement > EBITDA
-2263000
Quarters > 3 > income Statement > operating Margin
-991.1764705882354
Quarters > 3 > income Statement > total Other Income Expense Net
-30000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1226000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1395000
Quarters > 3 > balance Sheet > inventories
539000
Quarters > 3 > balance Sheet > total Current Assets
3160000
Quarters > 3 > balance Sheet > property Plant Equipment
279000
Quarters > 3 > balance Sheet > total Assets
3439000
Quarters > 3 > balance Sheet > payables
788000
Quarters > 3 > balance Sheet > short Term Debt
129000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1933000
Quarters > 3 > balance Sheet > equity
1506000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-2039000
Quarters > 3 > cash Flow > depreciation
118000
Quarters > 3 > cash Flow > change In Working Capital
-217000
Quarters > 3 > cash Flow > cash From Operations
-2410000
Quarters > 3 > cash Flow > capital Expenditures
5000
Quarters > 3 > cash Flow > cash From Investing
-5000
Quarters > 3 > cash Flow > cash From Financing
1040000
Quarters > 3 > cash Flow > net Change In Cash
-1375000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.01569963691798495
Quarters > 3 > ratios > PB
84.94520635790172
Quarters > 3 > ratios > ROE
-135.39176626826028
Quarters > 3 > ratios > ROA
-59.290491421924976
Quarters > 3 > ratios > FCF
-2415000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-10.147058823529411
Quarters > 3 > health Score
16
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
764000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
764000
Annuals > 0 > income Statement > operating Expenses
6144000
Annuals > 0 > income Statement > operating Income
-5380000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-5426000
Annuals > 0 > income Statement > net Income
-5231000
Annuals > 0 > income Statement > eps
-0.009293739459052165
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
562852017
Annuals > 0 > income Statement > income Tax Expense
-195000
Annuals > 0 > income Statement > EBITDA
-5359000
Annuals > 0 > income Statement > operating Margin
-704.1884816753926
Annuals > 0 > income Statement > total Other Income Expense Net
-46000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
1182000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1075000
Annuals > 0 > balance Sheet > inventories
428000
Annuals > 0 > balance Sheet > total Current Assets
2685000
Annuals > 0 > balance Sheet > property Plant Equipment
130000
Annuals > 0 > balance Sheet > total Assets
2815000
Annuals > 0 > balance Sheet > payables
589000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1377000
Annuals > 0 > balance Sheet > equity
1438000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-5426000
Annuals > 0 > cash Flow > depreciation
67000
Annuals > 0 > cash Flow > change In Working Capital
-389000
Annuals > 0 > cash Flow > cash From Operations
-5101000
Annuals > 0 > cash Flow > capital Expenditures
23000
Annuals > 0 > cash Flow > cash From Investing
-23000
Annuals > 0 > cash Flow > cash From Financing
1118000
Annuals > 0 > cash Flow > net Change In Cash
-4006000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.009293739459052165
Annuals > 0 > ratios > PB
332.701122705146
Annuals > 0 > ratios > ROE
-363.76912378303194
Annuals > 0 > ratios > ROA
-185.82593250444052
Annuals > 0 > ratios > FCF
-5124000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-6.706806282722513
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
501000
Annuals > 1 > income Statement > cost Of Revenue
247000
Annuals > 1 > income Statement > gross Profit
254000
Annuals > 1 > income Statement > operating Expenses
5813000
Annuals > 1 > income Statement > operating Income
-5312000
Annuals > 1 > income Statement > interest Expense
12000
Annuals > 1 > income Statement > pretax Income
-7750000
Annuals > 1 > income Statement > net Income
-7075000
Annuals > 1 > income Statement > eps
-0.03737410697146639
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
189302182
Annuals > 1 > income Statement > income Tax Expense
-675000
Annuals > 1 > income Statement > EBITDA
-7491000
Annuals > 1 > income Statement > operating Margin
-1060.2794411177645
Annuals > 1 > income Statement > total Other Income Expense Net
-2438000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
5188000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
125000
Annuals > 1 > balance Sheet > inventories
381000
Annuals > 1 > balance Sheet > total Current Assets
6626000
Annuals > 1 > balance Sheet > property Plant Equipment
174000
Annuals > 1 > balance Sheet > total Assets
6800000
Annuals > 1 > balance Sheet > payables
665000
Annuals > 1 > balance Sheet > short Term Debt
19000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1441000
Annuals > 1 > balance Sheet > equity
5359000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-5312000
Annuals > 1 > cash Flow > depreciation
247000
Annuals > 1 > cash Flow > change In Working Capital
407000
Annuals > 1 > cash Flow > cash From Operations
-3768000
Annuals > 1 > cash Flow > capital Expenditures
29000
Annuals > 1 > cash Flow > cash From Investing
1000
Annuals > 1 > cash Flow > cash From Financing
6364000
Annuals > 1 > cash Flow > net Change In Cash
2587000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.03737410697146639
Annuals > 1 > ratios > PB
30.02553735771599
Annuals > 1 > ratios > ROE
-132.02089942153387
Annuals > 1 > ratios > ROA
-104.04411764705883
Annuals > 1 > ratios > FCF
-3797000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-7.578842315369261
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
55000
Annuals > 2 > income Statement > cost Of Revenue
254000
Annuals > 2 > income Statement > gross Profit
-199000
Annuals > 2 > income Statement > operating Expenses
55000
Annuals > 2 > income Statement > operating Income
-5224000
Annuals > 2 > income Statement > interest Expense
31000
Annuals > 2 > income Statement > pretax Income
-5981000
Annuals > 2 > income Statement > net Income
-5150000
Annuals > 2 > income Statement > eps
-0.05469106213706441
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
94165295
Annuals > 2 > income Statement > income Tax Expense
-831000
Annuals > 2 > income Statement > EBITDA
-5696000
Annuals > 2 > income Statement > operating Margin
-9498.181818181818
Annuals > 2 > income Statement > total Other Income Expense Net
-757000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
2601000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
881000
Annuals > 2 > balance Sheet > inventories
525000
Annuals > 2 > balance Sheet > total Current Assets
4115000
Annuals > 2 > balance Sheet > property Plant Equipment
392000
Annuals > 2 > balance Sheet > total Assets
4507000
Annuals > 2 > balance Sheet > payables
432000
Annuals > 2 > balance Sheet > short Term Debt
222000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2466000
Annuals > 2 > balance Sheet > equity
2041000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-5224000
Annuals > 2 > cash Flow > depreciation
254000
Annuals > 2 > cash Flow > change In Working Capital
113000
Annuals > 2 > cash Flow > cash From Operations
-3776000
Annuals > 2 > cash Flow > capital Expenditures
52000
Annuals > 2 > cash Flow > cash From Investing
-37000
Annuals > 2 > cash Flow > cash From Financing
1824000
Annuals > 2 > cash Flow > net Change In Cash
-1988000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.05469106213706441
Annuals > 2 > ratios > PB
39.21631589906908
Annuals > 2 > ratios > ROE
-252.32729054385103
Annuals > 2 > ratios > ROA
-114.26669625027735
Annuals > 2 > ratios > FCF
-3828000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-69.6
Annuals > 2 > health Score
16
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
49000
Annuals > 3 > income Statement > cost Of Revenue
3871000
Annuals > 3 > income Statement > gross Profit
-3822000
Annuals > 3 > income Statement > operating Expenses
5414000
Annuals > 3 > income Statement > operating Income
-5615000
Annuals > 3 > income Statement > interest Expense
16000
Annuals > 3 > income Statement > pretax Income
-5631000
Annuals > 3 > income Statement > net Income
-4675000
Annuals > 3 > income Statement > eps
-0.05509058187909909
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
84860240
Annuals > 3 > income Statement > income Tax Expense
-956000
Annuals > 3 > income Statement > EBITDA
-5365000
Annuals > 3 > income Statement > operating Margin
-11459.183673469388
Annuals > 3 > income Statement > total Other Income Expense Net
-16000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
4589000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1003000
Annuals > 3 > balance Sheet > inventories
748000
Annuals > 3 > balance Sheet > total Current Assets
6415000
Annuals > 3 > balance Sheet > property Plant Equipment
206000
Annuals > 3 > balance Sheet > total Assets
6621000
Annuals > 3 > balance Sheet > payables
173000
Annuals > 3 > balance Sheet > short Term Debt
16000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1010000
Annuals > 3 > balance Sheet > equity
5611000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-4675000
Annuals > 3 > cash Flow > depreciation
250000
Annuals > 3 > cash Flow > change In Working Capital
-433000
Annuals > 3 > cash Flow > cash From Operations
-4610000
Annuals > 3 > cash Flow > capital Expenditures
62000
Annuals > 3 > cash Flow > cash From Investing
45000
Annuals > 3 > cash Flow > cash From Financing
6575000
Annuals > 3 > cash Flow > net Change In Cash
2015000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.05509058187909909
Annuals > 3 > ratios > PB
12.855320620210302
Annuals > 3 > ratios > ROE
-83.31848155409018
Annuals > 3 > ratios > ROA
-70.60866938528923
Annuals > 3 > ratios > FCF
-4672000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-95.34693877551021
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.004643977156574016
Valuation > metrics > PB
428.04031771905426
Valuation > final Score
20
Valuation > verdict
14168.0% Overvalued
Profitability > metrics > ROE
-201.80806675938805
Profitability > metrics > ROA
-108.08193668528865
Profitability > metrics > Net Margin
-4.804635761589404
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.9575799721835884
Risk > metrics > Interest Coverage
-117.08333333333333
Risk > final Score
-420
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.558573853989813
Liquidity > metrics > Quick Ratio
3.831918505942275
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-179
Prev Risks > 1
-2893
Prev Risks > 2
-1149
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:01:35.523Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides Genedrive system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a certified test for identification of individuals unlikely to respond to the commonly prescribed antiplatelet drug Clopidogrel. It also offers Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and tests for the detection of Antibiotic Induced Hearing Loss in neonates, confirmation of HCV infection prior to drug administration, pathogen detection of biological military threats and a point-of-care for COVID-19 detection system for use in areas, such as healthcare, workplace screening, travel requirements, and confirmation of antigen tests. It serves medical, biotechnology, and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. The company was founded in 2000 and is headquartered in Manchester, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AGTCO Completes GDR Delisting From London Stock Exchange Business Post Nigeria
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of genedrive plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.